1993
DOI: 10.1002/ccd.1810280306
|View full text |Cite
|
Sign up to set email alerts
|

Coronary artery spasm culminating in thrombosis following ergonovine stimulation

Abstract: A 53-yr-old active man with angina but no angiographically significant obstructive coronary artery disease developed refractory spasm following ergonovine provocation. This resulted in thrombus formation and myocardial infarction. As such, this is the first case in which thrombosis developed at the site of intense coronary artery spasm induced by ergonovine, all of which were documented angiographically. Despite the notable safety of this test, this case re-emphasizes the potential of ergonovine to produce int… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2000
2000
2021
2021

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 18 publications
0
4
0
Order By: Relevance
“…However, severe coronary vasospasm has been reported [3][4]. There have been few reports of severe coronary vasospasm-induced thrombus formation secondary to possible endothelial damage [5][6][7][8][9][10]. Endothelium of the coronary arteries inhibits platelet aggregation by formation and release of prostacyclin, and it reacts to platelet products by causing relaxation of the underlying smooth muscle.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…However, severe coronary vasospasm has been reported [3][4]. There have been few reports of severe coronary vasospasm-induced thrombus formation secondary to possible endothelial damage [5][6][7][8][9][10]. Endothelium of the coronary arteries inhibits platelet aggregation by formation and release of prostacyclin, and it reacts to platelet products by causing relaxation of the underlying smooth muscle.…”
Section: Discussionmentioning
confidence: 99%
“…Patients with coronary artery spasm usually have morphologic changes in the artery at the site of the spasm. Platelets can aggregate at this site and release vasoactive substances, which-aided by formation of thrombin-cause contraction [6,[8][9][10]. Literature shows coronary vasospasm occurring usually within one month of phentermine therapy [3][4].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Ergometrine is a potent vasoconstrictor, which is also used in provocation testing for coronary vasospasm. Refractory vasospasm culminating in MI is a recognised complication in this setting, and occlusive coronary artery spasm leading to in situ thrombosis has been shown angiographically 3. However, there have been only two previous reports of MI resulting from postpartum use of ergometrine 4…”
Section: Discussionmentioning
confidence: 99%